163 related articles for article (PubMed ID: 33583331)
1. Novel α-amylase and α-glucosidase inhibitors from selected Nigerian antidiabetic plants: an
Ogboye RM; Patil RB; Famuyiwa SO; Faloye KO
J Biomol Struct Dyn; 2022 Sep; 40(14):6340-6349. PubMed ID: 33583331
[TBL] [Abstract][Full Text] [Related]
2. 2,4-Dichloro-5-[(N-aryl/alkyl)sulfamoyl]benzoic Acid Derivatives: In Vitro Antidiabetic Activity, Molecular Modeling and In silico ADMET Screening.
Thakral S; Singh V
Med Chem; 2019; 15(2):186-195. PubMed ID: 30251608
[TBL] [Abstract][Full Text] [Related]
3. Identification of Major Compounds and α-Amylase and α-Glucosidase Inhibitory Activity of Rhizome of Musa balbisiana Colla: An in-vitro and in-silico Study.
Swargiary A; Daimari M
Comb Chem High Throughput Screen; 2022; 25(1):139-148. PubMed ID: 33234097
[TBL] [Abstract][Full Text] [Related]
4. In Silico Approaches to Identify Polyphenol Compounds as α-Glucosidase and α-Amylase Inhibitors against Type-II Diabetes.
Riyaphan J; Pham DC; Leong MK; Weng CF
Biomolecules; 2021 Dec; 11(12):. PubMed ID: 34944521
[TBL] [Abstract][Full Text] [Related]
5.
Osman W; Ismail EMOA; Shantier SW; Mohammed MS; Mothana RA; Muddathir A; Khalid HS
J Recept Signal Transduct Res; 2021 Apr; 41(2):159-169. PubMed ID: 32718219
[TBL] [Abstract][Full Text] [Related]
6. In silico evaluation of phenolic compounds as inhibitors of Α-amylase and Α-glucosidase.
Abdelli I; Benariba N; Adjdir S; Fekhikher Z; Daoud I; Terki M; Benramdane H; Ghalem S
J Biomol Struct Dyn; 2021 Feb; 39(3):816-822. PubMed ID: 31955660
[TBL] [Abstract][Full Text] [Related]
7. Screening alpha-glucosidase and alpha-amylase inhibitors from natural compounds by molecular docking in silico.
Jhong CH; Riyaphan J; Lin SH; Chia YC; Weng CF
Biofactors; 2015; 41(4):242-51. PubMed ID: 26154585
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of indole derivatives as diabetics II inhibitors and enzymatic kinetics study of α-glucosidase and α-amylase along with their in-silico study.
Taha M; Alrashedy AS; Almandil NB; Iqbal N; Anouar EH; Nawaz M; Uddin N; Chigurupati S; Wadood A; Rahim F; Das S; Venugopal V; Nawaz F; Khan KM
Int J Biol Macromol; 2021 Nov; 190():301-318. PubMed ID: 34481854
[TBL] [Abstract][Full Text] [Related]
9. Spiroindolone Analogues as Potential Hypoglycemic with Dual Inhibitory Activity on α-Amylase and α-Glucosidase.
Altowyan MS; Barakat A; Al-Majid AM; Al-Ghulikah HA
Molecules; 2019 Jun; 24(12):. PubMed ID: 31242688
[TBL] [Abstract][Full Text] [Related]
10. Differential α-amylase/α-glucosidase inhibitory activities of plant-derived phenolic compounds: a virtual screening perspective for the treatment of obesity and diabetes.
Rasouli H; Hosseini-Ghazvini SM; Adibi H; Khodarahmi R
Food Funct; 2017 May; 8(5):1942-1954. PubMed ID: 28470323
[TBL] [Abstract][Full Text] [Related]
11. In Vitro Evaluation of the Anti-Diabetic Potential of Aqueous Acetone
Akinyede KA; Oyewusi HA; Hughes GD; Ekpo OE; Oguntibeju OO
Molecules; 2021 Dec; 27(1):. PubMed ID: 35011387
[TBL] [Abstract][Full Text] [Related]
12. Novel enantiopure isoxazolidine and C-alkyl imine oxide derivatives as potential hypoglycemic agents: Design, synthesis, dual inhibitors of α-amylase and α-glucosidase, ADMET and molecular docking study.
Ghannay S; Snoussi M; Messaoudi S; Kadri A; Aouadi K
Bioorg Chem; 2020 Nov; 104():104270. PubMed ID: 32947132
[TBL] [Abstract][Full Text] [Related]
13. Antidiabetic potential of Catechu via assays for α-glucosidase, α-amylase, and glucose uptake in adipocytes.
Zhang K; Chen XL; Zhao X; Ni JY; Wang HL; Han M; Zhang YM
J Ethnopharmacol; 2022 Jun; 291():115118. PubMed ID: 35202712
[TBL] [Abstract][Full Text] [Related]
14. Feruloyl Sucrose Esters: Potent and Selective Inhibitors of α-glucosidase and α-amylase.
Devaraj S; Yip YM; Panda P; Ong LL; Wong PWK; Zhang D; Ali Y; Judeh Z
Curr Med Chem; 2022; 29(9):1606-1621. PubMed ID: 34455958
[TBL] [Abstract][Full Text] [Related]
15. Hypoglycemic Efficacy of Docking Selected Natural Compounds against α-Glucosidase and α-Amylase.
Riyaphan J; Jhong CH; Lin SR; Chang CH; Tsai MJ; Lee DN; Sung PJ; Leong MK; Weng CF
Molecules; 2018 Sep; 23(9):. PubMed ID: 30189596
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of flavonoids from banana pseudostem and flower (quercetin and catechin) as potent inhibitors of α-glucosidase: An in silico perspective.
Patil SM; Martiz RM; Ramu R; Shirahatti PS; Prakash A; Kumar BRP; Kumar N
J Biomol Struct Dyn; 2022; 40(23):12491-12505. PubMed ID: 34488558
[TBL] [Abstract][Full Text] [Related]
17. In silico molecular docking and in vitro antidiabetic studies of dihydropyrimido[4,5-a]acridin-2-amines.
Bharathi A; Roopan SM; Vasavi CS; Munusami P; Gayathri GA; Gayathri M
Biomed Res Int; 2014; 2014():971569. PubMed ID: 24991576
[TBL] [Abstract][Full Text] [Related]
18. Comparative study of the antidiabetic potential of
Tan DC; Idris KI; Kassim NK; Lim PC; Safinar Ismail I; Hamid M; Ng RC
Pharm Biol; 2019 Dec; 57(1):345-354. PubMed ID: 31185767
[No Abstract] [Full Text] [Related]
19. Steroidal saponins from Trillium govanianum as α-amylase, α-glucosidase, and dipeptidyl peptidase IV inhibitory agents.
Suresh PS; Singh PP; Padwad YS; Sharma U
J Pharm Pharmacol; 2021 Mar; 73(4):487-495. PubMed ID: 33793831
[TBL] [Abstract][Full Text] [Related]
20. Molecular dynamics simulations reveal the inhibitory mechanism of Withanolide A against α-glucosidase and α-amylase.
Oyewusi HA; Wu YS; Safi SZ; Wahab RA; Hatta MHM; Batumalaie K
J Biomol Struct Dyn; 2023; 41(13):6203-6218. PubMed ID: 35904027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
